Fall 2026
By Stevie Snow
Since joining the Dana-Farber Cancer Institute Board of Trustees in 2014, Phill Gross has supported Dana-Farber’s rapid growth and progress toward a world free from the burden of cancer. When Dana-Farber introduced plans for New England’s only dedicated inpatient cancer hospital to the Trustees, Phill was among the first to show support.
“Hospitals dedicated entirely to cancer care are rare. When you combine a world-class facility with the extraordinary talent at Dana-Farber, the potential to transform how cancer is treated isn’t just possible––it’s inevitable,” said Phill.
Phill and his wife, Liz Cochary Gross, PhD, invested in the future of cancer care fund at Dana-Farber through their family foundation, The JAKET Foundation, as part of their ongoing commitment to the scientific progress happening at Dana-Farber and influencing cancer treatments across the globe. Previously, their contributions helped accelerate translational research and funded programs to diversify and strengthen Dana-Farber’s nursing staff.
From an interlocking campus for seamlessly integrated care to circadian lighting in patient rooms, every detail of the Lavine Bekenstein Cancer Hospital at Dana-Farber will create a healing environment focused entirely on the needs of patients with cancer and their families. Phill and Liz were especially drawn to the garden terrace, a tranquil spot overlooking a multilevel garden for hospital visitors to pause, reflect, and recharge. It also connects to the dining pavilion, giving diners a calming space to eat while visiting loved ones.
The thoughtfully designed garden terrace will carry the Gross family’s name in recognition of their generous gift and steadfast belief in the leadership, researchers, and clinicians at Dana-Farber.
“We believe deeply in the importance of having a restorative space—for quiet reflection, rest, and renewal—when a patient or loved one is navigating cancer treatment,” Liz said. “Our hope is that the garden terrace offers exactly that kind of sanctuary for the patients and caregivers this hospital will serve.”
When you combine a world-class facility with the extraordinary talent at Dana-Farber, the potential to transform how cancer is treated isn’t just possible—it’s inevitable.
Phill Gross, Dana-Farber Trustee
Within the new hospital and beyond, Dana-Farber’s vision for the future of cancer care includes addressing holistic patient and family needs, implementing technologies that speed discovery, and investing in next-generation talent. Transformative supporters like Phill and Liz are critical to the spaces, people, and moments that will push the boundaries of what’s possible in cancer treatment and research.
“The experience patients will have at Dana-Farber’s new hospital––a place built entirely around cancer treatment and care––will be truly exceptional,” Phill said. “To help make that a reality in Boston, supported by such an extraordinary community of donors, physicians, nurses, and care partners, is a once-in-a-lifetime privilege for our family.”